source
- Alnylam shares tumble 30% even as biotech sector ralliesAlnylam's stock fell about 30% on July 28, 2026, even though the broader biotech market is experiencing a resurgence. The market rebound follows years of a bearish environment, with increased merg…
- Mirae secures $5.4 million to convert patient chatbot messages into clinical dataMirae, a health‑tech startup, announced it has closed a financing round that brought in $5.4 million. The capital will be used to develop its chatbot platform that encourages patients to describe…